Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel

New England Journal of Medicine

Volumn 354, Issue 2, 2006, Pages 151-157

  Milanesi, Raffaella ^a   Baruscotti, Mirko ^a   Gnecchi Ruscone, Tomaso ^b   DiFrancesco, Dario ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Merate Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; ION CHANNEL;

ARTICLE; AUTONOMIC INNERVATION; BINDING SITE; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; ELECTRIC POTENTIAL; EMBRYO; FAMILIAL DISEASE; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENETIC ASSOCIATION; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTANT; PRIORITY JOURNAL; SINUS BRADYCARDIA; SINUS NODE; VAGUS NERVE STIMULATION; WILD TYPE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARRHYTHMIA, SINUS; BASE SEQUENCE; BRADYCARDIA; CHILD; ELECTROPHYSIOLOGY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; ION CHANNELS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION, MISSENSE; PEDIGREE; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 30444452695     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa052475     Document Type: Article

References (25)

1. Sarachek NS, Leonard JL. Familial heart block and sinus bradycardia: classification and natural history. Am J Cardiol 1972;29:451-8.
2. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 1993;55:455-72.
3. Singh BN. Morbidity and mortality in cardiovascular disorders: impact of reduced heart rate. J Cardiovasc Pharmacol Ther 2001;6:313-31.
4. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective If current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004;64:1757-65.
5. Baruscotti M, Bucchi A, DiFrancesco D. Physiology and pharmacology of the cardiac pacemaker ("funny") current. Pharmacol Ther 2005;107:59-79.
6. Robinson RB, Siegelbaum SA. Hyper-polarization-activated cation currents: from molecules to physiological function. Annu Rev Physiol 2003;65:453-80.
7. Shi W, Wymore R, Yu H, et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 1999;85:e1-e6.
8. Seifert R, Scholten A, Gauss R, Mincheva A, Lichter P, Kaupp UB. Molecular characterization of a slowly gating human hyperpolarization-activated channel predominantly expressed in thalamus, heart, and testis. Proc Natl Acad Sci U S A 1999;96:9391-6.
9. Roden DM, Balser JR, George AL Jr, Anderson ME. Cardiac ion channels. Annu Rev Physiol 2002;64:431-75.
10. Viscomi C, Altomare C, Bucchi A, et al. C terminus-mediated control of voltage and cAMP gating of hyperpolarizationactivated cyclic nucleotide-gated channels. J Biol Chem 2001;276:29930-4.
11. DiFrancesco D, Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991;351:145-7.
12. DiFrancesco D, Mangoni M. Modulation of single hyperpolarization- activated channels (if) by cAMP in the rabbit sinoatrial node. J Physiol 1994;474:473-82.
13. Macfarlane PW, Lawrie TDV. Comprehensive electrocardiology: theory and practice in health and disease. New York: Pergamon Press, 1989.
14. Terwilliger JD, Ott J. Handbook of human genetics linkage. Baltimore: Johns Hopkins University Press, 1994.
15. Barbuti A, Baruscotti M, Altomare C, Moroni A, DiFrancesco D. Action of internal pronase on the f-channel kinetics in the rabbit SA node. J Physiol 1999;520:737-44.
16. Wainger BJ, DeGennaro M, Santoro B, Siegelbaum SA, Tibbs GR. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 2001;411:805-10.
17. Brown HF, DiFrancesco D, Noble SJ. How does adrenaline accelerate the heart? Nature 1979;280:235-6.
18. f) induced by acetylcholine in rabbit sino-atrial node myocytes. J Physiol 1988;405:477-91.
19. DiFrancesco D, Ducouret P, Robinson RB. Muscarinic modulation of cardiac rate at low acetylcholine concentrations. Science 1989;243:669-71.
20. Chen S, Wang J, Siegelbaum SA. Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide. J Gen Physiol 2001;117:491-504.
21. Schulze-Bahr E, Neu A, Friederich P, et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003;111:1537-45.
22. Ueda K, Nakamura K, Hayashi T, et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem 2004;279:27194-8.
23. Zagotta WN, Olivier NB, Black KD, Young EC, Olson R, Gouaux E. Structural basis for modulation and agonist specificity of HCN pacemaker channels. Nature 2003;425:200-5.
24. Vaca L, Stieber J, Zong X, Ludwig A, Hofmann F, Biel M. Mutations in the S4 domain of a pacemaker channel alter its voltage dependence. FEBS Lett 2000;479:35-40.
25. Chen J, Mitcheson JS, Tristani-Firouzi M, Lin M, Sanguinetti MC. The S4-S5 linker couples voltage sensing and activation of pacemaker channels. Proc Natl Acad Sci U S A 2001;98:11277-82.